Related Experiment Video
Updated: Jun 27, 2026

16:41
Experimental Approaches to Tissue Engineering
Published on: August 30, 2007
[Future challenges and prospects for drug companies]
1Entreprises du Médicament (LEEM), 88, rue de la Faisanderie 75782 Paris.
Bulletin De L'Academie Nationale De Medecine
|November 26, 2008
Summary
The French pharmaceutical industry faces global competition, requiring innovation and collaboration. Ensuring alignment between healthcare and industrial policies is crucial for France to lead in life sciences and healthcare.
Area of Science:
- Pharmaceutical industry
- Healthcare policy
- Life sciences innovation
Context:
- The global pharmaceutical landscape is rapidly evolving due to scientific and economic shifts.
- France possesses significant advantages in human resources, research, and production for the drug industry.
- Despite strengths, France is losing ground in international pharmaceutical competitiveness.
Purpose:
- To analyze the challenges facing the French pharmaceutical industry in a globalized market.
- To explore the necessity of adapting innovation models and production methods.
- To identify strategies for France to regain a leading position in life sciences and healthcare.
Summary:
- Drug companies must collaborate with healthcare professionals and public stakeholders for therapeutic advancement.
- France's pharmaceutical sector, despite its assets, is underperforming internationally.
- Key success factors include embracing collaborative public-private research and modernizing production.
Impact:
- Aligning national healthcare and industrial policies is paramount for France's future in life sciences.
- Enhanced cooperation among authorities, stakeholders, and companies is essential for achieving global leadership.
- Strategic coherence can reposition France as a world leader in the healthcare and life sciences sectors.
Related Concept Videos
Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Drug Control Governance: Regulatory Bodies and Their Impact
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...
Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Drug Administration and Therapy Phases: Overview
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...